ABEONA THERAPEUTICS INC. Business Finance Contracts & Agreements
57 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (3)
- Loan Agreements (2)
- Note Agreements (5)
- Purchase Agreements (8)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Security Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (7)
- Warrant Agreements (22)
- Form of Pre-Funded Warrant (Filed With SEC on May 3, 2024)
- Underwriting Agreement, dated May 3, 2024 (Filed With SEC on May 3, 2024)
- Supplement to the Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as... (Filed With SEC on January 8, 2024)
- Loan and Security Agreement, by and among Abeona Therapeutics, Inc., MacroChem Corporation, Abeona Therapeutics LLC, Avenue Venture Opportunities Fund, L.P., as Agent, and Avenue... (Filed With SEC on January 8, 2024)
- Warrant to Purchase Common Stock, by and between Abeona Therapeutics, Inc. and Avenue Venture Opportunities Fund II, L.P., dated as of January 8, 2024 (Filed With SEC on January 8, 2024)
- Warrant to Purchase Common Stock, by and between Abeona Therapeutics, Inc. and Avenue Venture Opportunities Fund, L.P., dated as of January 8, 2024 (Filed With SEC on January 8, 2024)
- Securities Purchase Agreement, dated July 3, 2023 (Filed With SEC on July 3, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on July 3, 2023)
- Securities Purchase Agreement dated November 3, 2022 (Filed With SEC on November 3, 2022)
- Form of Registration Rights Agreement (Filed With SEC on November 3, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on November 3, 2022)
- Form of Warrant (Filed With SEC on November 3, 2022)
- Form of Registration Rights Agreement by and among Abeona Therapeutics Inc. and the investors named therein, dated April 29, 2022 (Filed With SEC on May 2, 2022)
- Form of Securities Purchase Agreement between Abeona Therapeutics Inc. and the investors thereto, dated April 29, 2022 (Filed With SEC on May 2, 2022)
- Form of Warrant (Filed With SEC on December 17, 2021)
- Underwriting Agreement, dated December 17, 2021 (Filed With SEC on December 17, 2021)
- Description of Capital Stock of Abeona Therapeutics Inc (Filed With SEC on March 16, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on December 23, 2019)
- Underwriting Agreement, dated December 20, 2019, among the Company, Jefferies LLC and SVB Leerink LLC (Filed With SEC on December 23, 2019)
- Letter of Agreement and General Release dated October 1, 2018 between the Company and Jeffrey Davis (Filed With SEC on October 5, 2018)
- Underwriting Agreement between the Company and Jefferies LLC, as representative for the underwriters named therein, dated as of October 16, 2017 (Filed With SEC on October 17, 2017)
- 6,000,000 Shares Abeona Therapeutics Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2016)
- ABEONA THERAPEUTICS INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on August 26, 2016)
- PLASMATECH BIOPHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 14, 2015)
- PURCHASE AGREEMENT (Filed With SEC on August 3, 2015)
- PLASMATECH BIOPHARMACUETICALS, INC. Unsecured Grid Note (Filed With SEC on December 3, 2014)
- UNDERWRITING AGREEMENT between PLASMATECH BIOPHARMACEUTICALS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on November 6, 2014)
- FORM OF WARRANT AGENCY AGREEMENT (Filed With SEC on October 24, 2014)
- UNDERWRITING AGREEMENT between PLASMATECH BIOPHARMACEUTICALS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on October 24, 2014)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on October 23, 2014)
- EXHIBIT 10.33[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED.ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES... (Filed With SEC on August 14, 2013)
- CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES of SERIES B CUMULATIVE CONVERTIBLE PREFERRED STOCK of ACCESS PHARMACEUTICALS, INC. (Filed With SEC on October 26, 2012)
- COMMON STOCK PURCHASE WARRANT To Purchase [100% X (Issue Amount)/(Conversion Price)] Shares of Common Stock of ACCESS PHARMACEUTICALS, INC. (Filed With SEC on October 26, 2012)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 26, 2012)
- PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Access Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers October 25, 2012 (Filed With SEC on October 26, 2012)
- EXHIBIT 10.3 [FORM OF 5 YEAR WARRANT] (Filed With SEC on November 10, 2011)
- EXHIBIT 10.2 [FORM OF 2.5 YEAR WARRANT] (Filed With SEC on November 10, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 10, 2011)
- COMMON STOCK PURCHASE WARRANT ACCESS PHARMACEUTICALS, INC. (Filed With SEC on December 14, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 14, 2010)
